Cargando…

The AMPK pathway in fatty liver disease

Lipid metabolism disorders are the primary causes for the occurrence and progression of various liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) caused by a high-fat diet and ethanol. AMPK signaling pathway plays an important role in amelio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Chunqiu, Pan, Jianheng, Qu, Ning, Lei, Yuting, Han, Jiajun, Zhang, Jingzhou, Han, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531345/ https://www.ncbi.nlm.nih.gov/pubmed/36203933 http://dx.doi.org/10.3389/fphys.2022.970292

Ejemplares similares

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Protective Properties of FOXO1 Inhibition in a Murine Model of Non-alcoholic Fatty Liver Disease Are Associated With Attenuation of ER Stress and Necroptosis
por: Ding, Hao-ran, et al.
Publicado: (2020)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
por: Cao, Zhanhong, et al.
Publicado: (2021)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Inhibition of Hepatic AMPK Pathway Contributes to Free Fatty Acids-Induced Fatty Liver Disease in Laying Hen
por: Huang, Cheng, et al.
Publicado: (2022)

Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway
por: He, Wuyang, et al.
Publicado: (2021)

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Lipocalin-2 in Fructose-Induced Fatty Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017)

DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy
por: Yang, Ming, et al.
Publicado: (2021)

Effects of (Pro)renin Receptor on Diabetic Cardiomyopathy Pathological Processes in Rats via the PRR-AMPK-YAP Pathway
por: Xiong, Jie, et al.
Publicado: (2021)

Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease
por: Sun, Ji, et al.
Publicado: (2022)

Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1–AMPK Pathway
por: Luo, Xiu-ying, et al.
Publicado: (2021)

Role of AMPK in autophagy
por: Wang, Shengyuan, et al.
Publicado: (2022)

Silencing of miR-150-5p Ameliorates Diabetic Nephropathy by Targeting SIRT1/p53/AMPK Pathway
por: Dong, Wenmin, et al.
Publicado: (2021)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease
por: Keating, Michael F., et al.
Publicado: (2022)

Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway
por: Wang, Yan, et al.
Publicado: (2019)

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
por: Yu, Xiaochen, et al.
Publicado: (2022)

Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
por: Liu, Tianlong, et al.
Publicado: (2021)

Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation
por: Wang, Qinglan, et al.
Publicado: (2020)

Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice
por: Yang, You, et al.
Publicado: (2021)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease
por: Secor, Jordan D., et al.
Publicado: (2021)

Exercise-Induced Autophagy Suppresses Sarcopenia Through Akt/mTOR and Akt/FoxO3a Signal Pathways and AMPK-Mediated Mitochondrial Quality Control
por: Zeng, Zhengzhong, et al.
Publicado: (2020)

Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022)

Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes
por: He, Juan, et al.
Publicado: (2019)

Lipidomics analysis reveals new insights into the goose fatty liver formation
por: Wei, Rongxue, et al.
Publicado: (2022)

Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
por: Wen, Shuai, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
por: Sulaiman, Siti Aishah, et al.
Publicado: (2019)

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
por: Porras, David, et al.
Publicado: (2018)

Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease
por: Li, Na, et al.
Publicado: (2021)

Chronic Exercise Training Improved Aortic Endothelial and Mitochondrial Function via an AMPKα2-Dependent Manner
por: Chen, Xiaohui, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
por: Watt, Joanne, et al.
Publicado: (2022)

The bidirectional relationship between AMPK pathway activation and myokine secretion in skeletal muscle: How it affects energy metabolism
por: Ahsan, Mahdi, et al.
Publicado: (2022)

A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease
por: Desai, Poorvi, et al.
Publicado: (2013)

The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis
por: Mazzoccoli, Gianluigi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l4n9gvslbtgat27sce05h0ffq2